Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 18, 2008Clinical and Vaccine ImmunologyOpen Access

Concordant Proficiency in Measurement of T-Cell Immunity in Human Immunodeficiency Virus Vaccine Clinical Trials by Peripheral Blood Mononuclear Cell and Enzyme-Linked Immunospot Assays in Laboratories from Three Continents

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMark BoazSanofi (United States)PHPeter HayesInternational AIDS Vaccine InitiativeTTTony TarragonaInternational AIDS Vaccine Initiative

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Boaz et al. (2008) studied this question.

synapsesocial.com/papers/6a209eaaac6bb08424cd2aa6https://doi.org/10.1128/cvi.00326-08
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A modified human ELISPOT assay to detect specific responses to primary tumor cell targets2004 · 41 citations
  2. 2Differential Immunogenicity of Various Heterologous Prime-Boost Vaccine Regimens Using DNA and Viral Vectors in Healthy Volunteers2005 · 154 citations
  3. 3Optimization of whole blood antigen-specific cytokine assays for CD4+ T cells2000 · 147 citations
  4. 4Enhanced: The Need for a Global HIV Vaccine Enterprise2003 · 202 citations
  5. 5Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome1994 · 2,514 citations